2-Chloro-5-nitropyrimidine: Comprehensive Product Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Functional Applications
- 3. Implementation Scenarios
- 4. Industry Case Studies
- 5. Client Success Stories
- 6. Request Customized Solutions
1. Product Specifications & Comparative Analysis
| Parameter | 2-Chloro-5-nitropyrimidine | Analogous Compounds |
|---|---|---|
| CAS Number | 15862-53-0 | N/A |
| Molecular Formula | C4H2ClN3O2 | C4H3N3O2 (5-Nitropyrimidine) |
| Purity Grade | ≥98% (HPLC) | ≥95% (Standard Grade) |
| Storage Conditions | 2-8°C in inert atmosphere | Room temperature (General) |
2. Functional Applications
Core Utilization Areas:
- Pharmaceutical Intermediates: Key precursor for kinase inhibitors and antiviral agents
- Agrochemical Synthesis: Building block for neonicotinoid insecticides
- Material Science: Electron-deficient component in OLED materials
3. Implementation Scenarios
Typical Reaction Pathways:
| Process | Application |
|---|---|
| Nucleophilic Aromatic Substitution | Amine group introduction for drug candidates |
| Catalytic Cross-Coupling | Biaryl compound construction |
4. Industry Case Studies
Case 1: Anticancer Drug Development
Used in multistep synthesis of Bruton’s tyrosine kinase (BTK) inhibitor analogs, achieving 92% yield in Suzuki-Miyaura coupling reactions.
Case 2: Crop Protection Formulation
Key intermediate in next-generation systemic insecticides demonstrating 40% improved pest resistance management.
5. Client Success Stories
Client A: European Pharma Research Consortium
- Application: HIV protease inhibitor development
- Consumption: 15kg/month
- Result: Accelerated lead optimization phase by 6 months
Client B: Asian Agrochemical Manufacturer
- Application: Novel pesticide synthesis
- Consumption: 2.5 metric tons/quarter
- Result: Achieved 98.7% purity in final API
6. Request Customized Solutions
Contact our technical team for batch-specific specifications or custom synthesis requirements:
Email: info@vivalr.com
Tel: (86) 15866781826


评论
目前还没有评论。